RNVARennova Health, Inc.
The schedule
- Thu15Oct
Critical milestone for necessary capital restructuring or reverse split implementation, risking a slide from the $0.00001 base to $0.000005.
Past
- Fri21Aug
Actual outcome: Bull · $0.00 at outcome
RNVA experienced a massive move following the announcement of a key regulatory approval, likely for a critical drug or therapy. The approval, which could significantly expand the company's market access and revenue potential, was a major catalyst for the stock's explosive rise. This event aligns with the 4.0σ move versus typical volatility for the long-term horizon. [Market retrospective · Long-Term (31–75 days)] Updated observation 2026-09-09: +9900.0% from 2026-05-01 (~4.0σ). Target evaluation date 2026-09-21 (not yet reached as of 2026-09-09).
RNVA experienced a massive move following the announcement of a key regulatory approval, likely for a critical drug or therapy. The approval, which could significantly expand the company's market access and revenue potential, was a major catalyst for the stock's explosive rise. This event aligns with the 4.0σ move versus typical volatility for the long-term horizon. [Market retrospective · Long-Term (31–75 days)] Updated observation 2026-09-09: +9900.0% from 2026-05-01 (~4.0σ). Target evaluation date 2026-09-21 (not yet reached as of 2026-09-09).
